Health
COVID-19 vaccine candidate is 96.4 percent effective in mice, study shows – Drug Target Review
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
Posted: 1 December 2020 | Victoria Rees (Drug Target Review) | No comments yet
Administering two doses of a COVID-19 vaccine called BVX-0320 is effective in mouse models, a pre-clinical study has shown.
A new COVID-19 vaccine candidate has shown success in mouse models by inducing high levels of antibodies against the S1 fragment of the SARS-CoV-2 Spike (S) protein.
Developed by BioVaxys Technology, the vaccine, called BVX-0320, did not produce any toxicity in the mice. According to the researchers,…
-
Noosa News22 hours agoMan avoids jail for assaulting Brisbane bus driver, appears from custody on unrelated charges
-
Noosa News23 hours agoUpdate 1: Suspicious disappearance investigation, Kelvin Grove
-
Noosa News22 hours agoPotato mop-top virus detected at four more Tasmanian properties, including research plot
-
General24 hours agoBruce Lehrmann’s defence applies for messages allegedly sent to rape complainant by Network Ten lawyer in defamation case